Literature DB >> 12752748

Rapid and sensitive paradigm for screening patients with headache in primary care settings.

Morris Maizels1, Raoul Burchette.   

Abstract

OBJECTIVE: To determine the sensitivity and specificity of a brief headache screening paradigm for primary care clinicians.
BACKGROUND: Migraine and drug rebound headache are disabling primary headache disorders. Both are underdiagnosed and undertreated. A method for rapid screening of migraine, drug rebound headache, and other daily headache syndromes would be useful. The Brief Headache Screen uses 3 questions-the frequency of severe (disabling) headache, other (mild) headache, and use of symptomatic medication-to generate diagnoses.
METHODS: The Brief Headache Screen was evaluated in an emergency department, a family practice department, and a referral headache clinic. Diagnoses from the Brief Headache Screen were compared to diagnoses of trained researchers and headache specialists.
RESULTS: Three hundred ninety-nine patients were screened and interviewed. The criterion of episodic severe (disabling) headache correctly identified migraine in 136 (93%) of 146 patients with episodic migraine and 154 (78%) of 197 patients with chronic migraine, with a specificity for any migraine (episodic or chronic) of 32 (63%) of 51. The inclusion of episodic or daily severe headache identified migraine in 100% of patients with chronic migraine. Only 6 (1.7%) of 343 patients with migraine were not identified by severe (disabling) headache. The combination of severe and mild headache frequency was sensitive to daily headache syndromes in 218 (94%) of 232 patients with a specificity of 87 (54%) of 162. Medication overuse was correctly identified in 146 (86%) of 169 patients with a specificity of 22 (79%) of 28.
CONCLUSIONS: The frequency of severe (disabling) and mild headaches and use of symptomatic medications, rapidly and sensitively screens for migraine, daily headache syndromes, and medication overuse. The use of this paradigm in primary care settings may improve the recognition of these important headache syndromes.

Entities:  

Mesh:

Year:  2003        PMID: 12752748     DOI: 10.1046/j.1526-4610.2003.03088.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  9 in total

1.  The relation of PTSD symptoms to migraine and headache-related disability among substance dependent inpatients.

Authors:  Michael J McDermott; Joshua C Fulwiler; Todd A Smitherman; Kim L Gratz; Kevin M Connolly; Matthew T Tull
Journal:  J Behav Med       Date:  2015-11-26

2.  Symptomatic treatment of migraine: when to use NSAIDs, triptans, or opiates.

Authors:  Frederick R Taylor; Robert G Kaniecki
Journal:  Curr Treat Options Neurol       Date:  2011-02       Impact factor: 3.598

Review 3.  Migraine headache: options for acute treatment.

Authors:  Frederick R Taylor
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

4.  New uses of the Migraine Screen Questionnaire (MS-Q): validation in the Primary Care setting and ability to detect hidden migraine. MS-Q in Primary Care.

Authors:  Miguel J Láinez; Jesús Castillo; Manuel Domínguez; Gemma Palacios; Silvia Díaz; Javier Rejas
Journal:  BMC Neurol       Date:  2010-06-08       Impact factor: 2.474

5.  The burden of headache in China: validation of diagnostic questionnaire for a population-based survey.

Authors:  Sheng-Yuan Yu; Xiu-Tang Cao; Gang Zhao; Xiao-Su Yang; Xiang-Yang Qiao; Yan-Nan Fang; Jia-Chun Feng; Ruo-Zhuo Liu; Timothy J Steiner
Journal:  J Headache Pain       Date:  2011-03-31       Impact factor: 7.277

6.  Validation of a Georgian language headache questionnaire in a population-based sample.

Authors:  Maka Kukava; Anna Dzagnidze; Marina Janelidze; Eka Mirvelashvili; Mamuka Djibuti; Guenther Fritsche; Rigmor Jensen; Lars J Stovner; Timothy J Steiner; Zaza Katsarava
Journal:  J Headache Pain       Date:  2007-12-10       Impact factor: 7.277

7.  Probable medications overuse headaches: validation of a brief easy-to-use screening tool in a headache centre.

Authors:  Virginie Dousset; Martial Maud; Mélanie Legoff; Françoise Radat; Bruno Brochet; Jean-François Dartigues; Tobias Kurth
Journal:  J Headache Pain       Date:  2013-10-02       Impact factor: 7.277

8.  Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria.

Authors:  Kolawole Wahab; Asuwemhe Ugheoke; Peter Okokhere; Titus Ibekwe
Journal:  Ethiop J Health Sci       Date:  2016-01

9.  Diagnostic and classification tools for chronic headache disorders: A systematic review.

Authors:  Rachel Potter; Katrin Probyn; Celia Bernstein; Tamar Pincus; Martin Underwood; Manjit Matharu
Journal:  Cephalalgia       Date:  2018-10-18       Impact factor: 6.292

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.